Skip to main content
SpringerLink
Log in

Topical Corticosteroid Therapy of Rhinitis

A Review

  • Review Article
  • Drug Class Overview
  • Published:
Clinical Immunotherapeutics Aims and scope Submit manuscript

Summary

The introduction of nasal corticosteroids 20 years ago has been the most important therapeutic progress in rhinitis management since the introduction of the first generation of antihistamines. Our knowledge of the mode of action of corticosteroids is still incomplete, although a series of intranasal studies has now clarified this problem as the airway mucous membrane of the nose is easily accessible for investigation. Nasal corticosteroids are a highly effective therapeutic modality that can be used for long term therapy of allergic rhinitis, perennial nonallergic rhinitis and nasal polyposis. Experience for 20 years has shown that the adverse effects from this type of treatment are negligible, and far less serious than those occurring in the skin following long term use of corticosteroid ointment. Intranasal corticosteroids can therefore be considered as first-line treatment for allergic and nonallergic rhinitis.

The major disadvantage of this type of treatment is the slow onset of action and the lack of effect on itchy eyes. For that reason, the second generation antihistamines are the drugs of choice in patients having occasional symptoms. However, in our opinion, intranasal corticosteroids are preferable in patients who have symptoms on a regular basis, either in the pollen season or all year.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pepys J, Hutchroft BJ. Bronchial provocation tests in etiologic diagnosis and analysis of asthma. Am Rev Respir Dis 1975; 112: 928–59

    Google Scholar 

  2. Bisgaard H, Gronborg H, Mygind N, et al. Allergen-induced increase of eosinophil cationic protein in nasal lavage fluid: effect of the glucocorticoid budesonide. J Allergy Clin Immunol 1990; 85: 891–5

    Article  PubMed  CAS  Google Scholar 

  3. Horak F, Matthew H. The protective action of fluocortin butylester (FCB) in the nasal antigen provocation test: a controlled double-blind crossover study. Ann Allergy 1982; 48: 305

    PubMed  CAS  Google Scholar 

  4. Okuda M, Senba O. Effect of beclomethasone dipropionate nasal spray on subjective and objective findings in perennial rhinitis. Clin Otolaryngol 1980; 53: 15–21

    Google Scholar 

  5. Pipkom U. Budesonide and nasal allergen challenge testing in man. Allergy 1982; 37: 129–34

    Article  Google Scholar 

  6. Pipkorn U, Proud D, Schleimer RP, et al. Effects of short term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest 1987; 80: 957–61

    Article  PubMed  CAS  Google Scholar 

  7. Vilsviik JS, Jenssen AO, Walstad R. The effect of beclomethasone dipropionate aerosol on allergen induced nasal stenosis. Clin Allergy 1975; 5: 291–4

    Article  Google Scholar 

  8. Dahl R, Johansson S-Å. Importance of duration of treatment with inhaled budesonide on the immediate and late bronchial reaction. Eur J Respir Dis 1982; 63Suppl. 122: 167–75

    Google Scholar 

  9. Pipkorn U. Budesonide and nasal histamine challenge. Allergy 1982; 37: 359–63

    Article  PubMed  CAS  Google Scholar 

  10. Pipkorn U. Effect of topical glucocorticoid treatment on nasal mucosal mast cells in allergic rhinitis. Allergy 1983; 38: 125–9

    Article  PubMed  CAS  Google Scholar 

  11. Pipkorn U, Andersson P. Budesonide and nasal mucosal histamine content and anti-IgE induced histamine release. Allergy 1982; 37: 591–5

    Article  PubMed  CAS  Google Scholar 

  12. Lindqvist N, Karlsson G, Pipkorn U. Adrenoceptor responsiveness of the allergic nasal mucosa. Effect of topical glucocorticoid treatment. ORL J Otorhinolaryngol Relat Spec. In press

  13. Bende M, Lindqvist N, Pipkorn U. The effect of a topical steroid, budesonide, on nasal mucosal blood flow as measured with 133Xe wash-out technique. Allergy 1983; 38: 461–4

    Article  PubMed  CAS  Google Scholar 

  14. Baumgarten CR, Togias A, Naclerio RM, et al. Kininogens are generated following nasal challenge with allergen in allergen individuals but not in non-allergic individuals. J Clin Invest 1985; 76: 191–7

    Article  PubMed  CAS  Google Scholar 

  15. Proud D, Togias A, Naclerio RM, et al. Kinins are generated in-vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest 1983; 72: 1678–85

    Article  PubMed  CAS  Google Scholar 

  16. Pipkorn U, Proud D, Lichtenstein LM, et al. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med 1987; 316: 1506–10

    Article  PubMed  CAS  Google Scholar 

  17. Sørensen H, Mygind N, Pedersen CB, et al. Long term treatment of nasal polyps with beclomethasone dipropionate aerosol III. Acta Otolaryngol (Stockh) 1976; 82: 260–2

    Article  Google Scholar 

  18. Svensson C, Klementsson H, Andersson M, et al. Glucocorticoid-induced attenuation of mucosal exudation of fibrinogen and bradykinins in seasonal allergic rhinitis. Allergy 1994; 49: 177–83

    Article  PubMed  CAS  Google Scholar 

  19. Grønborg H, Bisgaard H, Rømeling F, et al. Nasal symptom response to allergen provocation: effect of the glucocorticoid budesonide. Allergy 1993; 48: 87–93

    Article  PubMed  Google Scholar 

  20. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 1988; 81: 580–9

    Article  PubMed  CAS  Google Scholar 

  21. Naclerio RM. Inflammation in allergic rhinitis. Res Clin Forums 1992; 14(3): 49–55

    Google Scholar 

  22. Okuda M, Othsuka H, Sakaguchi K, et al. Effect of anti-allergic treatment on nasal surface basophilic metachromatic cells in allergic rhinitis. Allergy Proc 1989; 10: 23–6

    Article  PubMed  CAS  Google Scholar 

  23. Bascom R, Pipkorn U, Lichtenstein LM, et al. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic corticosteroids. Am Rev Respir Dis 1988; 138: 406–12

    PubMed  CAS  Google Scholar 

  24. Andersson M, Andersson P, Venge P, et al. Eosinophils and eosinophil cationic protein (ECP) in nasal lavages during allergen-induced hyperresponsiveness. Effect of topical glucocorticosteroid treatment. Allergy 1989; 44: 342–8

    Article  PubMed  CAS  Google Scholar 

  25. Gomez E, Clague J, Gatland D, et al. Effect of topical corticosteroids on seasonally induced increase in nasal mast cells. BMJ 1988; 246: 1572–3

    Article  Google Scholar 

  26. Otsuka H, Denburg JA, Befus AD, et al. Effect of beclomethasone dipropionate on nasal metachromatic cell sub-population. Clin Allergy 1986; 16: 589–95

    Article  PubMed  CAS  Google Scholar 

  27. Pipkorn U, Enerbäck L. Nasal mucosal mast cells and histamine in hay fever: effect of topical glucocorticoid treatment. Int Arch Allergy Appl Immunol 1987; 84: 123–8

    Article  PubMed  CAS  Google Scholar 

  28. Meltzer EO, Orgel HA, Bronshy EA, et al. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology. J Allergy Clin Immunol 1990; 86: 221–30

    Article  PubMed  CAS  Google Scholar 

  29. Meltzer EO, Orgel HA, Rogenes PR, et al. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate. J Allergy Clin Immunol 1994; 94: 708–15

    Article  PubMed  CAS  Google Scholar 

  30. Mygind N, Sørensen H, Pedersen CB. The nasal mucosa during long-term treatment with beclomethasone dipropionate aerosol. A light and scanning electron microscopic study of nasal polyps. Acta Otolaryngol (Stockh) 1978; 85: 437–43

    CAS  Google Scholar 

  31. Andersson M, Andersson P, Pipkom U. Allergen-induced specific and non-specific nasal hyperreactivity. Reciprocal relationship and inhibition by topical glucocorticosteroids. Acta Otolaryngol (Stockh) 1989: 107; 270–7

    Article  CAS  Google Scholar 

  32. Andersson M, Andersson P, Pipkom U. Topical glucocorticosteroids and allergen-induced increase in nasal reactivity. Relationship between treatment time and inhibitory effect. J Allergy Clin Immunol 1988; 82: 1019–26

    Article  PubMed  CAS  Google Scholar 

  33. Baroody F, Lichtenstein LM, Kagey-Sobotka A, et al. Topical steroids inhibit antigen-induced nasal hyperreactivity to histamine [abstract]. J Allergy Clin Immunol 1989; 82: 163

    Google Scholar 

  34. Ryan G, Latimer KM, Juniper EF, et al. Effect of beclomethasone dipropionate on bronchial responsiveness to histamine in controlled nonsteroid-dependent asthma. J Allergy Clin Immunol 1985; 75: 25–30

    Article  PubMed  CAS  Google Scholar 

  35. Klementsson H, Svensson C, Andersson M, et al. Eosinophils, secretory responsiveness and glucocorticoid-induced effects on the nasal mucosa during a weak pollen season. Clin Exp Allergy 1991; 21: 705–10

    Article  PubMed  CAS  Google Scholar 

  36. Malm L, Wihl J-Å, Lamm CJ, et al. Reduction of methacholine induced nasal secretions by the treatment with a new topical steroid in perennial non-allergic rhinitis. Allergy 1982; 36: 209–14

    Article  Google Scholar 

  37. Toft A, Wihl J-Å, Toxman J, et al. Double-blind comparison between beclomethasone dipropionate as aerosol and as powder in patients with nasal polyposis. Clin Allergy 1982; 12: 391–401

    Article  PubMed  CAS  Google Scholar 

  38. van Wijk RG. Nasal hyperresponsiveness to histamine, methacholine and phentolamine in allergic rhinitis patients and controls. Clin Allergy 1987; 17: 563–70

    Article  Google Scholar 

  39. Holm AF, Fokkens WJ, Godthelp T, et al. Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995; 50: 204–9

    Article  PubMed  CAS  Google Scholar 

  40. Kay AB. Asthma and inflammation. J Allergy Clin Immunol 1991; 87: 893–910

    Article  PubMed  CAS  Google Scholar 

  41. Rak S, Jacobson MR, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994; 24: 930–9

    Article  PubMed  CAS  Google Scholar 

  42. Masuyama K, Rak S, Jacobson MR, et al. Rhinitis at the cellular level. Eur Respir Rev 1994; 4: 252–5

    Google Scholar 

  43. Kanai N, Denburg JA, Evans S, et al. Nasal polyp inflammation. Effect of topical nasal steroid. Am J Respir Crit Care Med 1994; 150: 1094–1100

    PubMed  CAS  Google Scholar 

  44. Cox G, Ohtoshi T, Vancheri C, et al. Promotion of eosinophil survival by human bronchial epithelial cells and its modulation by steroids. Am J Respir Cell Mol Biol 1991; 4: 525–31

    PubMed  CAS  Google Scholar 

  45. Mattoli S, Vittori E, Marini M. Corticosteroids downregulate the increased expression of GM-CSF, IL6 and IL8 in bronchial epithelium of asthmatic patients [abstract]. J Allergy Clin Immunol 1992; 89: 164

    Google Scholar 

  46. Brogden RN, Heel RC, Speight TM, et al. Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis. Drugs 1984; 28: 99–126

    Article  PubMed  CAS  Google Scholar 

  47. Brogden RN, McTavish D. Budesonide: an updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis. Drugs 1992; 44(3): 375–407

    Article  PubMed  CAS  Google Scholar 

  48. Naclerio RM, Mygind N. Intranasal steroids. In: Mygind N, Naclerio RM, editors. Allergic and non-allergic rhinitis: clinical aspects. Copenhagen: Munksgaard, 1993: 114–22

    Google Scholar 

  49. Pakes GE, Brogden RN, Heel RD, et al. Flunisolide: a review of its pharmacological properties and therapeutic efficacy in rhinitis. Drugs 1980; 19: 397–411

    Article  PubMed  CAS  Google Scholar 

  50. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992; 43(5) 760–75

    Article  PubMed  CAS  Google Scholar 

  51. Siegel SC. Topical intranasal corticosteroid therapy in rhinitis. J Allergy Clin Immunol 1988; 81: 984–91

    Article  PubMed  CAS  Google Scholar 

  52. Lund VJ. International consensus report on the diagnosis and management of rhinitis. Allergy 1994; 49Suppl. 19: 1–34

    Google Scholar 

  53. Norman PS, Winkenwerder WL, Agbayani BF, et al. Adrenal function during the use of dexamethasone aerosols in the treatment of ragweed hay fever. J Allergy Clin Immunol 1967; 40: 57–61

    CAS  Google Scholar 

  54. Stevens DJ. Cushing’s syndrome due to abuse of betamethasone nasal drops. J Laryngol Otol 1988; 102: 219–21

    Article  PubMed  CAS  Google Scholar 

  55. Czarny D, Brostoff J. Effect of intranasal betamethasone-17-valerate on perennial rhinitis and adrenal function. Lancet 1968; 2: 188–90

    Article  PubMed  CAS  Google Scholar 

  56. Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in hay fever. BMJ 1973; 4: 464–6

    Article  PubMed  CAS  Google Scholar 

  57. Turkeltaub PC, Norman PS, Crepea S. Treatment of ragweed hay fever with an intranasal spray containing flunisolide: a new synthetic corticosteroid. J Allergy Clin Immunol 1976; 58: 597–606

    Article  PubMed  CAS  Google Scholar 

  58. Balle VH, Pedersen U, Engby B. Allergic perennial and non-allergic vasomotor rhinitis treated with budesonide nasal spray. Rhinology 1980; 18: 135–42

    PubMed  CAS  Google Scholar 

  59. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84Suppl. A: 25–9

    Article  PubMed  Google Scholar 

  60. Scadding GK, Lund VJ, Holmstrand M, et al. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1991; Suppl. 11: 37–43

    Google Scholar 

  61. Dolovich J, Wong AG, Chodirker WB, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 1994; 72: 147–53

    Google Scholar 

  62. Findley S, Huber F, Garcia J, et al. Efficacy of once-a-day intranasal administration of triamcinolone acetonide in patients with seasonal allergic rhinitis. Ann Allergy 1992; 68: 228–32

    Google Scholar 

  63. Orgel HA, Meltzer EO, Bierman CW, et al. Intranasal fluocortin butyl in patients with perennial rhinitis: a 12-month efficacy and safety study including nasal biopsy. J Allergy Clin Immunol 1991; 88: 257–64

    Article  PubMed  CAS  Google Scholar 

  64. Sahay JN, Chatterjee SS, Engler C. A comparative trial of flunisolide and beclomethasone dipropionate in the treatment of perennial allergic rhinitis. Clin Allergy 1980; 10: 65–70

    Article  PubMed  CAS  Google Scholar 

  65. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc 1987; 62: 125–34

    Article  PubMed  CAS  Google Scholar 

  66. Radner PH, Pauli BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1992; 90: 285–91

    Article  Google Scholar 

  67. van As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective in perennial rhinitis as twice daily beclomethasone dipropionate. J Allergy Clin Immunol 1993; 91: 1146–54

    Article  PubMed  Google Scholar 

  68. LaForce CF, Dockhorn RJ, Findlay SR, et al. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract 1994; 38: 145–52

    PubMed  CAS  Google Scholar 

  69. Haye R, Gomez EG. A multicenter study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1993; 31: 169–74

    PubMed  CAS  Google Scholar 

  70. al Mohaimeid H. A parallel-group comparison of budesonide and beclomethasone dipropionate for the treatment of perennial allergic rhinitis in adults. J Int Med Res 1993; 21: 67–73

    PubMed  CAS  Google Scholar 

  71. Vanzieleghem MA, Juniper EF. A comparison of budesonide and beclomethasone dipropionate nasal aerosols in ragweed-induced rhinitis. J Allergy Clin Immunol 1987; 79: 887–92

    Article  PubMed  CAS  Google Scholar 

  72. McArthur JG. A comparison of budesonide and beclomethasone dipropionate sprays in the treatment of seasonal allergic rhinitis. Clin Otolaryngol 1994; 19: 537–42

    Article  PubMed  CAS  Google Scholar 

  73. Storms W, Bronsky E, Findley S, et al. Once daily triamcinolone acetonide nasal spray is effective for the treatment of perennial allergic rhinitis. Ann Allergy 1991; 66: 329–34

    PubMed  CAS  Google Scholar 

  74. Welch MJ, Bronsky EA, Grossman J, et al. Clinical evaluation of triamcinolone acetonide nasal aerosol in children with perennial allergic rhinitis. Ann Allergy 1991; 67: 493–8

    PubMed  CAS  Google Scholar 

  75. van As A, Bronsky E, Grossman J, et al. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991; 67: 156–62

    PubMed  Google Scholar 

  76. Kwaselow A, MacLean J, Busse W, et al. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. J Allergy Clin Immunol 1985; 40: 363–7

    Article  CAS  Google Scholar 

  77. Lindqvist N, Andersson M, Bende M, et al. The clinical efficacy of budesonide in hay fever treatment is dependent on topical nasal application. Clin Exp Allergy 1989; 19: 71–6

    Article  PubMed  CAS  Google Scholar 

  78. Hallworth GW, Padfield JM. A comparison of regional deposition in a model nose of a drug discharged from metered aerosol and metered-pump nasal delivery system. J Allergy Clin Immunol 1986; 77: 348–53

    Article  PubMed  CAS  Google Scholar 

  79. Mygind N, Vesterhauge S. Aerosol distribution in the nose. Rhinology 1978; 16: 79–88

    PubMed  CAS  Google Scholar 

  80. Newman SP, Moren F, Clarke SW. Deposition pattern from a nasal pump spray. Rhinology 1987; 25: 77–82

    PubMed  CAS  Google Scholar 

  81. Batts AH, Marriott C, Martin GP, et al. The effect of some preservatives used in nasal preparations on mucociliary clearance. J Pharm Pharmacol 1989; 41: 156–9

    Article  PubMed  CAS  Google Scholar 

  82. Berg ØH, Lie K, Steinvåg SK. The effect of decongestive nosedrops on human respiratory mucosa in vitro. Laryngoscope 1994; 104: 1153–8

    Article  PubMed  CAS  Google Scholar 

  83. Stafanger G. In vitro effect of beclomethasone dipropionate and flunisolide on mobility of human nasal cilia. Allergy 1987; 42: 507–11

    Article  PubMed  CAS  Google Scholar 

  84. Orgel HA, Meltzer EO, Kemp JP, et al. Clinical, rhinomanometric, and cytological evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosol. J Allergy Clin Immunol 1986; 77: 858–64

    Article  PubMed  CAS  Google Scholar 

  85. Johansen LV, Ilium P, Kristensen S, et al. The effect of budesonide in the treatment of small and medium-sized nasal polyps. Clin Otolaryngol 1993; 18: 524–7

    Article  Google Scholar 

  86. Pedersen B, Larsen BB, Dahl R, et al. Powder administration of pure budesonide for the treatment of seasonal allergic rhinitis. Allergy 1991; 46: 582–7

    Article  PubMed  CAS  Google Scholar 

  87. Pedersen B, Larsen BB, Dahl R, et al. Budesonide powder administration for the treatment of grass-pollen-induced allergic rhinitis. Allergy 1994; 49: 855–60

    Article  PubMed  CAS  Google Scholar 

  88. Thorsson L, Newman SP, Weiz A, et al. Nasal distribution of budesonide inhaled via a powder inhaler. Rhinology 1993; 31: 7–10

    PubMed  CAS  Google Scholar 

  89. Agertoft L, Wolthers OD, Fuglsang G, et al. Nasal powder administration for seasonal rhinitis in children and adolescents. Pediatr Allergy Immunol 1993; 4: 152–6

    Article  PubMed  CAS  Google Scholar 

  90. Larsen C, Jørgensen MN, Tommerup B, et al. Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin. Eur J Clin Pharmacol 1987; 33: 155–9

    Article  PubMed  CAS  Google Scholar 

  91. Grossman J, Banov C, Bronsky EA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993; 92: 594–9

    PubMed  CAS  Google Scholar 

  92. Dahl R. The effect of fluticasone propionate aqueous nasal spray in seasonal rhinitis [abstract]. Allergy 1992; 47Suppl. 12: 346

    Google Scholar 

  93. Dolovich J, O’Connor M, Stepner N, et al. Double-blind comparison of intranasal fluticasone propionate, 200µg, once daily with 200µg twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed. Ann Allergy 1994; 72: 435–440

    PubMed  CAS  Google Scholar 

  94. Malm L, Wihl J-Å. Intranasal beclomethasone dipropionate in vasomotor rhinitis. Acta Allerg (Kbh) 1976; 31: 245–50

    Article  CAS  Google Scholar 

  95. Wight RG, Jones AS, Beckingham E, et al. A double-blind comparison of intranasal budesonide 400%g and 800%g in perennial rhinitis. Clin Otolaryngol 1992; 17: 354–8

    Article  PubMed  CAS  Google Scholar 

  96. Lildholdt T, Rundcrantz H, Lindqvist N. Effect of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide. Clin Otolaryngol 1995; 20: 26–30

    Article  PubMed  CAS  Google Scholar 

  97. Munch E, Gomez G, Mygind N, et al. An open comparison of dosage frequency of beclomethasone dipropionate in seasonal allergic rhinitis. Clin Allergy 1981; 11: 303–9

    Article  PubMed  CAS  Google Scholar 

  98. Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991; 67: 332–8

    PubMed  CAS  Google Scholar 

  99. Banov CH, Woehler TR, LaForce CF, et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994; 73: 240–6

    PubMed  CAS  Google Scholar 

  100. Bousquet J, Chanal I, Alquié MC, et al. Prevention of pollen rhinitis. Comparison of fluticasone propionate aqueous nasal spray versus disodium cromoglycate nasal spray. Allergy 1993; 48: 327–33

    Article  PubMed  CAS  Google Scholar 

  101. Beswick KB, Kenyon GS, Cherry JR. A comparative study of beclomethasone dipropionate aqueous nasal spray with terfenadine tablets in season allergic rhinitis. Curr Med Res Opin 1985; 9: 560–7

    Article  PubMed  CAS  Google Scholar 

  102. Bunnag C, Jareoncharsri P, Wong ECK. A double-blind comparison of nasal budesonide and oral astemizole for the treatment of perennial rhinitis. Allergy 1992; 47: 313–7

    Article  PubMed  CAS  Google Scholar 

  103. Charpin D, Vervloet D. Treating seasonal rhinitis: antihistamines or intranasal corticosteroids? Eur Respir Rev 1994; 4: 256–9

    Google Scholar 

  104. Frølund L. Efficacy of an oral antihistamine, loratadine, as compared with a nasal steroid spray, beclomethasone dipropionate, in seasonal allergic rhinitis. Clin Otolaryngol 1992; 16: 527–31

    Article  Google Scholar 

  105. Harding SM, Heath S. Intranasal steroid aerosol in perennial rhinitis: comparison with an antihistamine compound. Clin Allergy 1976; 6: 369–72

    Article  PubMed  CAS  Google Scholar 

  106. Juniper EF, Kline PA, Hargreave FE, et al. Comparison of beclomethasone dipropionate aqueous spray, astemizole, and the combination in the prophylactic treatment of ragweed-induced rhinoconjunctivitis. J Allergy Clin Immunol 1989; 83: 627–33

    Article  PubMed  CAS  Google Scholar 

  107. Munch E, Søborg M, Nørreslet TT, et al. A comparative study of dexchlorpheniramine maleate sustained tablets and budesonide nasal spray in seasonal allergic rhinitis. Allergy 1983; 38: 517–24

    Article  PubMed  CAS  Google Scholar 

  108. Salomonsson P, Gottberg L, Heilborn H, et al. Efficacy of an oral antihistamine, astemizole, as compared to a nasal steroid spray in hay fever. Allergy 1988; 43: 214–8

    Article  PubMed  CAS  Google Scholar 

  109. Simpson RJ. Budesonide and terfenadine, separately and in combination, in the treatment of hay fever. Ann Allergy 1994; 73: 497–502

    PubMed  CAS  Google Scholar 

  110. Davies RJ, Lund VJ, Harten-Ash VJ. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology 1993; 31: 159–64

    PubMed  CAS  Google Scholar 

  111. Dorow P, Aurich R, Petzold U. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Drug Res 1993; 43: 909–12

    CAS  Google Scholar 

  112. Gastpar H, Aurich R, Petzold U, et al. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol. Arzneimittelforschung 1993; 43: 475–9

    PubMed  CAS  Google Scholar 

  113. Negrini AC, Troise C, Voltolini S, et al. Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis. Clin Exp Allergy 1995; 25: 60–5

    Article  PubMed  CAS  Google Scholar 

  114. Wood SFG. Oral antihistamine and nasal steroid in hay fever. Clin Allergy 1986; 16: 195–201

    Article  PubMed  CAS  Google Scholar 

  115. Wihl J-Å, Petersen BN, Petersen LN, et al. Effect of the non-sedative H1-receptor antagonist astemizole in perennial allergic and nonallergic rhinitis. J Allergy Clin Immunol 1985; 75: 720–7

    Article  PubMed  CAS  Google Scholar 

  116. Benincasa C, Lloyd RS. Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest 1994; 8: 225–33

    Article  Google Scholar 

  117. Pipkorn U, Rundcrantz H, Lindqvist N. Budesonide — a new nasal steroid. Rhinology 1980; 18: 171–5

    PubMed  CAS  Google Scholar 

  118. Siegel SC, Katz R, Rachelefsky GS, et al. Multicenter study of beclomethasone dipropionate in adults with seasonal allergic rhinitis. J Allergy Clin Immunol 1982; 69: 345–53

    Article  PubMed  CAS  Google Scholar 

  119. Cockcroft DW, MacCormack DW, Newhouse MT, et al. Beclomethasone dipropionate in allergic rhinitis. Can Med Assoc J 1976; 115: 523–6

    PubMed  CAS  Google Scholar 

  120. Henriksen J, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis 1984; 130: 1014–8

    PubMed  CAS  Google Scholar 

  121. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma. J Allergy Clin Immunol 1988; 81: 1042–7

    Article  PubMed  CAS  Google Scholar 

  122. Aubier M, Levy J, Clerici C, et al. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis. Am Rev Respir Dis 1992; 146: 122–6

    PubMed  CAS  Google Scholar 

  123. Corren J, Adinoff AD, Buchmeier AD, et al. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol 1992; 90: 250–6

    Article  PubMed  CAS  Google Scholar 

  124. Tarlo SM, Cockroft DW, Dolovich J, et al. Beclomethasone dipropionate aerosol in perennial rhinitis. J Allergy Clin Immunol 1977; 59: 232–6

    Article  PubMed  CAS  Google Scholar 

  125. Hansen I, Mygind N. Local effect of intranasal beclomethasone dipropionate aerosol in perennial rhinitis. Acta Allerg (Kbh) 1974; 29: 281–7

    Article  CAS  Google Scholar 

  126. Lindqvist N, Balle V, Karma P, et al. Long term safety and efficacy of budesonide nasal aerosol in perennial rhinitis — a 12 month multicenter study. Allergy 1986; 41: 179–86

    Article  PubMed  CAS  Google Scholar 

  127. Löfkvist T, Svensson G. Treatment of vasomotor rhinitis with beclomethasone dipropionate. Acta Allerg (Kbh) 1976; 31: 227–38

    Article  Google Scholar 

  128. Pipkorn U, Pukander J, Suonpaa J, et al. Long-term safety of budesonide nasal aerosol — a 5½ year follow up study. Clin Allergy 1988; 18: 253–9

    Article  PubMed  CAS  Google Scholar 

  129. Feiss G, Welch M, Meltzer E, et al. The predictive value of nasal eosinophilia for therapeutic response to intranasal corticosteroid treatment in perennial allergic rhinitis [abstract]. J Allergy Clin Immunol 1992; 89: 209

    Article  Google Scholar 

  130. Small P, Black M, Frenkiel S. Effect of treatment with beclomethasone dipropionate in subpopulations of perennial rhinitis patients. J Allergy Clin Immunol 1982; 70: 78–82

    Article  Google Scholar 

  131. Whelan CFA. Problems in the examination of nasal smears in allergic rhinitis. J Laryngol Otol 1980; 84: 399–405

    Article  Google Scholar 

  132. Chaplin I, Haynes JT, Spahn I. Are nasal polyps an allergic phenomenon? Ann Allergy 1971; 29: 63–4

    Google Scholar 

  133. Delaney JC. Aspirin idiosyncrasy in patients admitted for nasal polypectomy. Clin Otolaryngol 1976; 1: 27–30

    Article  PubMed  CAS  Google Scholar 

  134. Deuschl H, Drettner B. Nasal polyps treated with beclomethasone nasal aerosol. Rhinology 1977; 15: 17–23

    PubMed  CAS  Google Scholar 

  135. Holopainen E, Grahne B, Malmberg H, et al. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis 1982; 63Suppl. 122: 221–8

    Google Scholar 

  136. Mygind N, Pedersen CB, Prytz S, et al. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975; 5: 159–64

    Article  PubMed  CAS  Google Scholar 

  137. Mygind N, Lildholdt T. Treatment: medical management. In: Settipane GA, Lund VJ, Bernstein JM, et al., editors. Nasal polyps: epidemiology, pathogenesis and treatment. Providence: OceanSide Publications, 1995. In press

    Google Scholar 

  138. Drettner B, Ebbesen A, Nilsson M. Prophylactic treatment with flunisolide after polypectomy. Rhinology 1982; 20: 149–58

    PubMed  CAS  Google Scholar 

  139. Karlsson G, Rundcrantz H. A randomized trial of intranasal beclomethasone dipropionate after polypectomy. Rhinology 1982; 20: 144–8

    PubMed  CAS  Google Scholar 

  140. Farr BM, Gwaltney JM, Hendley JO, et al. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis 1990; 162: 1173–7

    Article  PubMed  CAS  Google Scholar 

  141. Meltzer EO, Busse WW, Druce HM, et al. Assessment of flunisolide nasal spray versus placebo as an adjunct to antibiotic treatment of sinusitis [abstract]. J Allergy Clin Immunol 1992; 89: 301

    Google Scholar 

  142. Sykes DA, Wilson R, Chan KL, et al. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. Lancet 1986; 2: 359–60

    Article  PubMed  CAS  Google Scholar 

  143. Boner AL, Sette L. Rhinitis in children: efficacy and safety of a new intranasal corticosteroid. Eur Respir Rev 1994; 20: 271–3

    Google Scholar 

  144. Schatz M, Zeiger RS, editors. Asthma and allergy in pregnancy and early infancy. New York: Marcel Dekker, 1993: 1–636

    Google Scholar 

  145. Soderberg-Warner ML. Nasal septal perforation associated with topical corticosteroid therapy. J Pediatr 1984; 105: 840–1

    Article  PubMed  CAS  Google Scholar 

  146. Brown HM, Storey G, Jackson FA. Beclomethasone dipropionate aerosol in treatment of perennial and seasonal rhinitis: a review of five years’ experience. Br J Clin Pharmacol 1977; 4Suppl. 3: 283–6

    Article  Google Scholar 

  147. Sarnstrand B, Jeppsson Å, Malmstrom A, et al. Effect of glucocorticosteroids on hyaluronic acid synthesis in vitro in human fibroblast-like cells from lung and skin. In: Hogg JC, Ellul-Micalef R, Brattsand R, editors. Glucocorticosteroids, inflammation and bronchial hyperreactivity. Amsterdam: Excerpta Medica, 1985: 157–66

    Google Scholar 

  148. Frauenfelder FT, Myer SM. Posterior subcapsular cataracts associated with nasal or inhalation corticosteroids. Am J Oph: thalmol 1990; 109: 489–90

    Google Scholar 

  149. Simons FE, Persaud MP, Gillespie CA, et al. Absence of posterior cataracts in young patients treated with inhaled glucocorticoids. Lancet 1993; 342: 776–8

    Article  PubMed  CAS  Google Scholar 

  150. Wolthers OD, Pedersen S. Kneemometry assessment of systemic activity of once daily intranasal dry-powder budesonide in children. Allergy 1994; 49: 96–9

    Article  PubMed  CAS  Google Scholar 

  151. Knutsson U, Stjärna P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol. In press

Download references

Author information

Authors and Affiliations

  1. Otopathological Laboratory, Department of Otorhinolaryngology, and Allergy Clinic, Department of Internal Medicine, Rigshospitalet, DK-2100, Copenhagen, Denmark

    Niels Mygind

  2. Institute of Laryngology and Otology, University College London Medical School, London, England

    Valerie Lund

Authors
  1. Niels Mygind
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valerie Lund
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mygind, N., Lund, V. Topical Corticosteroid Therapy of Rhinitis. Clin. Immunother. 5, 122–136 (1996). https://doi.org/10.1007/BF03259319

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03259319

Keywords

Search

Navigation